Cargando…

Real-World Management of Patients with Primary Biliary Cholangitis—A Retrospective Study from a Tertiary Medical Center in Israel

Background: Primary biliary cholangitis (PBC) is a rare autoimmune liver disease with variation in prevalence, phenotype and prognosis across different geographical regions. Little is known about PBC in Israel. Our aim was to characterize the demography, clinical presentation, treatment patterns and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yehezkel, Eyal, Israel, Inbal, Houri, Inbal, Leshno, Moshe, Shibolet, Oren, Zigmond, Ehud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509713/ https://www.ncbi.nlm.nih.gov/pubmed/34640567 http://dx.doi.org/10.3390/jcm10194551

Ejemplares similares

Emergency department targeted screening for hepatitis C does not improve linkage to care
por: Houri, Inbal, et al.
Publicado: (2020)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale
por: Levy, Cynthia, et al.
Publicado: (2018)

Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
por: Roberts, Surain B., et al.
Publicado: (2020)

Real-world experience with obeticholic acid in patients with primary biliary cholangitis
por: D’Amato, Daphne, et al.
Publicado: (2021)

The Critical Role of Chemokine (C–C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis
por: Reuveni, Debby, et al.
Publicado: (2018)

Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis
por: Reuveni, Debby, et al.
Publicado: (2021)

Older age, longer procedures and tandem endoscopic-ultrasound as risk factors for post-endoscopic retrograde cholangiopancreatography bacteremia
por: Deutsch, Liat, et al.
Publicado: (2020)

Gender and Cutaneous Leishmaniasis in Israel
por: Solomon, Michal, et al.
Publicado: (2022)

Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
por: Shlomai, Amir, et al.
Publicado: (2021)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus
por: Bar, Nir, et al.
Publicado: (2022)

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
por: Greenman, Raanan, et al.
Publicado: (2023)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

Identifying and assessing views among physically-active adult gym members in Israel on dietary supplements
por: Druker, Inbal, et al.
Publicado: (2017)

Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany
por: Wilde, Anne-Christin Beatrice, et al.
Publicado: (2021)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Enhancing intensive care capacity: COVID-19 experience from a Tertiary Center in Israel
por: Leshem, Eyal, et al.
Publicado: (2020)

Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel
por: Fogelman, Yacov, et al.
Publicado: (2016)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

The Effects of Surgical Approaches and Enhanced Recovery Protocols on the Cost Effectiveness of Radical Cystectomy
por: Kord, Eyal, et al.
Publicado: (2022)

Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial
por: Deutsch, Liat, et al.
Publicado: (2020)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis
por: Turvey, Shannon L., et al.
Publicado: (2022)

Regional variations in mortality and causes of death in Israel, 2009–2013
por: Gordon, Ethel-Sherry, et al.
Publicado: (2017)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_obn1bern0v5is218tsd9s3tqhq